Screener Summaries Updates Institutions Sign In More Updates › Other Events › BGM Other Events · Jul 28, 2026
BGM Group Ltd. regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing its Form 20-F annual report for… BGM BGM Group Ltd.
BGM Group Ltd. regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing its Form 20-F annual report for the fiscal year ended September 30, 2025, on July 21, 2026. The Nasdaq Staff confirmed compliance on July 24, 2026, resolving the deficiency that arose from the delayed filing. The company operates in the biotechnology and pharmaceutical industry.
More from BGM Group Ltd. BGM Group Ltd. announced a 30-for-one share consolidation to be effective October 1, 2026, following shareholder… Sep 24, 2026 BGM Group Ltd filed its unaudited financial results for the six months ended March 31, 2026 Aug 28, 2026 BGM Group Ltd is convening an Extraordinary General Meeting on September 5, 2026, to approve a 30-for-1 reverse share… Aug 11, 2026 BGM Group Ltd announced the resignation of Mr. Chen Xin as Chairman of the Board and Co-Chief Executive Officer… Jul 30, 2026 At an extraordinary general meeting on July 9, 2026, shareholders approved resolutions authorizing the board of… Jul 13, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
